Violeta manages the regulatory and legal affairs of the healthcare biotechnology team of the European association for Bioindustries – EuropaBio.
She is coordinating the work of EuropaBio’s expert groups of leading biopharmaceutical companies on ATMPs, human gene editing and regulatory policy. In this role, Violeta is in regular contacts with the European Medicines Agency, the European Commission, and other health stakeholders.
On ATMPs, Violeta’s main topics have been centred around the objective to enhance the regulatory environment for novel treatments in the EU – in the areas of scientific advice, GMO requirements for the conduct of clinical trials, real-world evidence, etc.
Along with this, Violeta’s mission in Brussels is to raise the awareness of EU and national policy makers as well as the patient representation community of the value of advanced therapies.
After graduating from Law School and before joining EuropaBio in 2014, Violeta has been trained at the European Patent Office, the European Parliament and the European Commission. She is also specialised in Intellectual Property Rights.
